Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Dirigidas en Enfermedades Reumáticas

Biobadaser Fase III

Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study. EBioMedicine. 2016;11:302-6.

28/02/2022

Courvoisier DS, Alpizar-Rodriguez D, Gottenberg JE, Hernandez MV, Iannone F, Lie E, et al.

Epub 2016/08/26. doi: 10.1016/j.ebiom.2016.08.024. PubMed PMID: 27558858; PubMed Central PMCID: PMCPMC5049989.